Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma

Shahryari, 2019, Development and clinical translation of approved gene therapy products for genetic disorders, Front. Genet., 10, 868, 10.3389/fgene.2019.00868 Das, 2015, Gene Therapies for Cancer: Strategies, Challenges and Successes, J. Cell. Physiol., 230, 259, 10.1002/jcp.24791 Lundstrom, 2018, Viral Vectors in Gene Therapy, Diseases., 6, 42, 10.3390/diseases6020042 Yazdani, 2018, Gene Therapy: A New Approach in Modern Medicine, Int. J. Med. Rev., 5, 106, 10.29252/IJMR-050304 Goswami, 2019, Gene therapy leaves a vicious cycle, Front. Oncol., 9, 297, 10.3389/fonc.2019.00297 Heller, 2011, Electroporation based gene therapy - From the bench to the bedside, Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBS, Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., 736 Arjmand, 2020, The horizon of gene therapy in modern medicine: Advances and challenges, Adv. Exp. Med. Biol., Springer, 33 Young, 2015, Electroporation-Mediated Gene Delivery, Adv. Genet., 89, 49, 10.1016/bs.adgen.2014.10.003 Cemazar, 2019, Recent Advances in Electrochemotherapy, Bioelectricity, 1, 204, 10.1089/bioe.2019.0028 Edhemovic, 2020, Intraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II study, Eur. J. Surg. Oncol., 1628, 10.1016/j.ejso.2020.04.037 Djokic, 2020, Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: Technological advancement, Radiol. Oncol., 54, 347, 10.2478/raon-2020-0038 Brloznik, 2019, Radiological findings of porcine liver after electrochemotherapy with bleomycin, Radiol. Oncol., 53, 10.2478/raon-2019-0049 Rosazza, 2016, Gene Electrotransfer: A Mechanistic Perspective, Curr. Gene Ther., 16, 98, 10.2174/1566523216666160331130040 Chiarella, 2008, Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration, Expert Opin. Biol. Ther., 8, 1645, 10.1517/14712598.8.11.1645 Reed, 2009, Electroporation Advances in Large Animals, Curr. Gene Ther., 9, 316, 10.2174/156652309788921062 Chiarella, 2009, Recent Advances in Epitope Design for Immunotherapy of Cancer, Recent Pat. Anticancer. Drug Discov., 4, 227, 10.2174/157489209789206922 Calvet, 2014, Optimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in mice, Mol. Ther. - Methods Clin. Dev., 1, 14045, 10.1038/mtm.2014.45 Sieni, 2020, The Efficiency of Gene Electrotransfer in Breast-Cancer Cell Lines Cultured on a Novel Collagen-Free 3D Scaffold, Cancers (Basel), 12, 1043, 10.3390/cancers12041043 De Robertis, 2018, In vivo evaluation of a new recombinant hyaluronidase to improve gene electro-transfer protocols for dna-based drug delivery against cancer, Cancers (Basel), 10, 405, 10.3390/cancers10110405 Heller, 2000, In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity, Melanoma Res., 10, 577, 10.1097/00008390-200012000-00010 Hanna, 2001, Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site, Cancer Gene Ther., 8, 151, 10.1038/sj.cgt.7700287 Daud, 2008, Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma, J. Clin. Oncol., 26, 5896, 10.1200/JCO.2007.15.6794 Greaney, 2020, Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses, Cancer Immunol. Res., 8, 246, 10.1158/2326-6066.CIR-19-0359 Algazi, 2020, Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma, Clin. Cancer Res., 26, 2827, 10.1158/1078-0432.CCR-19-2217 Algazi, 2020, Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients, Ann. Oncol., 31, 532, 10.1016/j.annonc.2019.12.008 Lucas, 2002, IL-12 plasmid delivery by in Vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma, Mol. Ther., 5, 668, 10.1006/mthe.2002.0601 Heller, 2006, Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model, Clin. Cancer Res., 12, 3177, 10.1158/1078-0432.CCR-05-2727 Berraondo, 2019, Cytokines in clinical cancer immunotherapy, Br. J. Cancer., 120, 6, 10.1038/s41416-018-0328-y Cemazar, 2015, 24 Electroporation for Electrochemotherapy and Gene Therapy, 395 Shirley, 2020, Electrotransfer of il-15/il-15rα complex for the treatment of established melanoma, Cancers (Basel), 12, 1, 10.3390/cancers12103072 Zundler, 2015, Interleukin-12: Functional activities and implications for disease, Cytokine Growth Factor Rev., 26, 559, 10.1016/j.cytogfr.2015.07.003 Nguyen, 2020, Localized Interleukin-12 for Cancer Immunotherapy, Front. Immunol., 11, 10.3389/fimmu.2020.575597 Cemazar, 2010, Cancer Electrogene Therapy with Interleukin-12, Curr. Gene Ther., 10, 300, 10.2174/156652310791823425 Cha, 2012, Plasmid IL-2 electroporation in melanoma, Hum. Vaccines Immunother., 8, 1734, 10.4161/hv.22573 Jiang, 2016, Role of IL-2 in cancer immunotherapy, Oncoimmunology., 5, 10.1080/2162402X.2016.1163462 Ross, 2018, Signaling and Function of Interleukin-2 in T Lymphocytes, Annu. Rev. Immunol., 36, 411, 10.1146/annurev-immunol-042617-053352 Horton, 2008, IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial, Methods Mol. Biol., 423, 361, 10.1007/978-1-59745-194-9_28 Zhao, 2012, Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R, PLoS ONE, 7, 46241, 10.1371/journal.pone.0046241 Wang, 2000, Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4, Blood, 95, 3183, 10.1182/blood.V95.10.3183 Castro, 2018, Interferon-gamma at the crossroads of tumor immune surveillance or evasion, Front. Immunol., 9, 847, 10.3389/fimmu.2018.00847 Duan, 2020, Turning Cold into Hot: Firing up the Tumor Microenvironment, Trends Cancer., 6, 605, 10.1016/j.trecan.2020.02.022 Baird, 2013, Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge, J. Immunol., 190, 469, 10.4049/jimmunol.1201209 Bosnjak, 2015, Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma, Gene Ther., 22, 578, 10.1038/gt.2015.26 Lee, 2012, Agarose gel electrophoresis for the separation of DNA fragments, J. Vis. Exp., 3923 Van Acker, 2019, Selecting Appropriate Reference Genes for Quantitative Real-Time Polymerase Chain Reaction Studies in Isolated and Cultured Ocular Surface Epithelia, Sci. Rep., 9, 1, 10.1038/s41598-019-56054-1 Percie du Sert, 2020, The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research, PLOS Biol., 18 W. Rasband, ImageJ. Bethesda, Maryland: US National Institutes of Health. https://imagej.nih.gov/ij/, 2016 (30 november 2020). Mastrodonato, 2017, A histochemical approach to glycan diversity in the urothelium of pig urinary bladder, Microsc. Res. Tech., 80, 239, 10.1002/jemt.22794 C. Zaiontz, Real statistical analysis using Excel. https://www.real-statistics.com, 2019 (accessed 30 november 2020). Chávez-Galán, 2015, Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages, Front. Immunol., 6, 263 Gollob, 1999, The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation, J. Immunol., 8, 4472, 10.4049/jimmunol.162.8.4472 Tevz, 2009, Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas, J. Gene Med., 11, 1125, 10.1002/jgm.1403 Sano, 2014, In-vitro bipolar nano- and microsecond electro-pulse bursts for irreversible electroporation therapies, Bioelectrochemistry, 100, 69, 10.1016/j.bioelechem.2014.07.010 Bosnjak, 2018, Electrotransfer of different control plasmids elicits different antitumor effectiveness in B16.F10 melanoma, Cancers (Basel), 10, 37, 10.3390/cancers10020037 Heller, 2010, Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas, Cancer Gene Ther., 17, 864, 10.1038/cgt.2010.43 Miranda-Hernández, 2013, Expression of Foxp3, CD25 and IL-2 in the B16F10 cancer cell line and melanoma is correlated with tumor growth in mice, Oncol. Lett., 6, 1195, 10.3892/ol.2013.1526 Cemazar, 2009, Control by pulse parameters of DNA electrotransfer into solid tumors in mice, Gene Ther., 16, 635, 10.1038/gt.2009.10 Andre, 2008, Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin, Hum. Gene Ther., 19, 1261, 10.1089/hum.2008.060 Haberl, 2013, Effect of different parameters used for in vitro gene electrotransfer on gene expression efficiency, cell viability and visualization of plasmid DNA at the membrane level, J. Gene Med., 15, 169, 10.1002/jgm.2706 Pavlin, 2015, New Insights into the Mechanisms of Gene Electrotransfer - Experimental and Theoretical Analysis, Sci. Rep., 5, 9132, 10.1038/srep09132 Sersa, 2008, Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma, Br. J. Cancer., 98, 388, 10.1038/sj.bjc.6604168 Pasquet, 2018, Safe and efficient novel approach for non-invasive gene electrotransfer to skin, Sci. Rep., 8, 16833, 10.1038/s41598-018-34968-6 Chiarella, 2010, Application of Electroporation in DNA Vaccination Protocols, Curr. Gene Ther., 10, 281, 10.2174/156652310791823506 Chiarella, 2013, Electroporation in DNA Vaccination Protocols Against Cancer, Curr. Drug Metab., 14, 291, 10.2174/1389200211314030004 Vogel, 2012, Insights into the regulation of protein abundance from proteomic and transcriptomic analyses, Nat. Rev. Genet., 13, 227, 10.1038/nrg3185 Lucas, 2003, IL-12 Gene Therapy Using an Electrically Mediated Nonviral Approach Reduces Metastatic Growth of Melanoma, DNA Cell Biol., 22, 755, 10.1089/104454903322624966 Shirley, 2014, Controlled Gene Delivery Can Enhance Therapeutic Outcome for Cancer Immune Therapy for Melanoma, Curr. Gene Ther., 15, 32, 10.2174/1566523214666141121111630 Heller, 2006, In vivo electroporation for gene therapy, Hum. Gene Ther., 17, 890, 10.1089/hum.2006.17.890 Teulings, 2015, Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: A systematic review and meta-analysis, J. Clin. Oncol., 33, 773, 10.1200/JCO.2014.57.4756 Richards, 2007, Phase I trial of IL-2 plasmid DNA with electroporation in metastatic melanoma, J. Clin. Oncol., 25, 8578, 10.1200/jco.2007.25.18_suppl.8578 Lampreht Tratar, 2017, Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma, Mediators Inflamm., 2017, 5285890, 10.1155/2017/5285890 Shi, 2018, IL-12 gene electrotransfer triggers a change in immune response within mouse tumors, Cancers (Basel), 10, 498, 10.3390/cancers10120498 Tugues, 2015, New insights into IL-12-mediated tumor suppression, Cell Death Differ., 22, 237, 10.1038/cdd.2014.134 Weiss, 2007, Immunotherapy of cancer by IL-12-based cytokine combinations, Expert Opin. Biol. Ther., 7, 1705, 10.1517/14712598.7.11.1705 Wigginton, 2002, IL-12/IL-2 combination cytokine therapy for solid tumours: Translation from bench to bedside, Expert Opin. Biol. Ther., 2, 513, 10.1517/14712598.2.5.513 Pavlin, 2009, Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma, Cancer Biol. Ther., 8, 2114, 10.4161/cbt.8.22.9734 Li, 2004, Candidate genes associated with tumor regression mediated by intratumoral Il-12 electroporation gene therapy, Mol. Ther., 9, 347, 10.1016/j.ymthe.2003.11.022 Skrombolas, 2014, Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy, Expert Rev. Clin. Immunol., 10, 207, 10.1586/1744666X.2014.875856 Ascierto, 2017, Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th-3rd December 2016, J. Transl. Med., 15, 236, 10.1186/s12967-017-1341-2 Veglia, 2017, Dendritic cells in cancer: the role revisited, Curr. Opin. Immunol., 45, 43, 10.1016/j.coi.2017.01.002 E. Weagel, C. Smith, P.G. Liu, R. Robison, K. O’neill, Macrophage Polarization and Its Role in Cancer, (2015) 6. https://doi.org/10.4172/2155-9899.1000338. Zhang, 2019, Systemic Interferon-g Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a phase 0 clinical trial, Cancer Immunol Res., 7, 1237, 10.1158/2326-6066.CIR-18-0940